PLENTIVECTOR

Welcome to the Brand page for “PLENTIVECTOR”, which is offered here for Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections, leukemia and bodily conditions associated with impaired immunosystem;chemical compositions containing nucleic acids for use in the manufacture of pharmaceutical and retroviral vector preparations;medical services;scientific and medical product research and development, genetic engineering services for scientific and medical research use, biotechnology services, research and development of new products in the field of biotechnology, genetic engineering services for scientific and medical research use;.

Its status is currently believed to be active. Its class is unavailable. “PLENTIVECTOR” is believed to be currently owned by “Oxford BioMedica plc”.